Case report shows significant improvement of junctional epidermolysis bullosa with oral dapsone, indicating its potential as a therapeutic option.
Dapsone is a potent antibacterial agent used as a first‐line treatment for leprosy and employed also as an anti‐inflammatory agent. Additionally, dapsone is used for a variety of other cutaneous conditions. Herein, we report a case of intermediate junctional epidermolysis bullosa that improved significantly with oral 4,4’‐diamino‐diphenyl sulfone (dapsone).
No takes yet. Share an insight, caveat, or question.
Fujimoto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: